Newsletter

Subscribe to our newsletter to stay informed.

Newsletter Overlay EN
Salutation
* Mandatory fields
Policy

Your order has been added!

Order

Publications

Number

Publication

Language

Shop EN
Greetings
*Required fields
Policy
Titelbild der Interpharma-Publikation «Animal Welfare Report 2022» (englische Version)

Animal Welfare Report 2022

Interpharma members are constantly working to develop new research methods and to minimise the number of laboratory animals. However, animal experiments remain essential for researching ubiquitous diseases such as cancer, multiple sclerosis and Alzheimer’s disease, and in developing new treatments. It is therefore important that pharmaceutical companies give top priority to responsible animal use and actively implement the 10-point Animal Welfare Charter adopted by member companies of Interpharma in 2010.

Animal Welfare Report 2022

Add to cart

Please select the quantity

First page of the Executive Insight position paper 'MFN: Looking forward'

Pharma Location Switzerland

MFN: Looking forward

MFN is already affecting Switzerland: companies are delaying or pausing launches. Low Swiss prices remain a strategic vulnerability beyond 2029, so Switzerland should prepare now.

MFN: Looking forward

Add to cart

Please select the quantity

Factsheet «Der Forschungsstandort Schweiz» von Interpharma

Research and Development

Der Forschungsstandort Schweiz

Der Forschungsstandort Schweiz

Add to cart

Please select the quantity

Titelbild der gfs.bern-Studie «Gesundheitsmonitor 2026»

Patient Value

Studie

Gesundheitsmonitor 2026

Gesundheitsmonitor 2026

Add to cart

Please select the quantity